Earth Science Tech, Inc. (OTC: ETST) has announced the acquisition of Meduvo LLC, a compounding pharmacy located in La Verne, California. This strategic move establishes a West Coast operational hub and expands the company's pharmacy network to 34 U.S. jurisdictions. The acquisition is a significant step in Earth Science Tech's mission to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine, and direct-to-patient fulfillment.
Meduvo currently operates from a 2,000-square-foot facility and specializes in compounding and dispensing non-sterile medications. Earth Science Tech is initiating facility upgrades designed to meet sterility requirements, with management targeting full regulatory certification for sterile compounding by the end of 2028. The company stated that regulatory approvals are pending in additional states as it pursues nationwide coverage.
This acquisition aligns with Earth Science Tech's principal operating strategy to create a seamless integration of patient care, from consultation to fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. The core value proposition lies in the synergy of its specialized subsidiaries, which include compounding pharmacy operations and telemedicine platforms.
The expansion into California is particularly notable given the state's large population and demand for specialized compounding services. By adding Meduvo to its network, Earth Science Tech can better serve patients on the West Coast while leveraging its existing infrastructure to scale operations. The company's focus on sterile compounding certification reflects a growing trend in the pharmaceutical industry toward higher-quality, customized medications.
Investors may view this acquisition as a positive indicator of Earth Science Tech's growth trajectory. The company has been actively expanding its footprint through strategic acquisitions and regulatory approvals. The announcement comes as part of a broader effort to consolidate the healthcare supply chain and offer integrated services that improve patient outcomes.
While the company did not disclose the financial terms of the transaction, the move is expected to enhance its competitive position in the compounding pharmacy market. Earth Science Tech's management has expressed confidence in the deal, citing Meduvo's established operations and the potential for future growth.
For more information about Earth Science Tech, visit the company's newsroom at https://ibn.fm/ETST. To view the full press release, visit https://ibn.fm/wMvIu.
